Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PREDECT Resource Report Resource Website 1+ mentions |
PREDECT (RRID:SCR_003883) | PREDECT | consortium, data or information resource, organization portal, portal | Project that aims to create more appropriate in vitro platforms for target validation and drug discovery for breast, prostate and lung cancers. Laboratory platforms to validate whether target modulation would provide a clinical benefit are usually highly reductionist, often using long-established cell lines growing in 2 dimensions in vitro. These models do not reflect the complexity and heterogeneity of a tumor in situ, where biochemical pathways are wired with connections to the complex tumor environment provided by the stroma. PREDECT has the goal of comparing the pathological and molecular profiles of novel in vitro platforms with those of human tumors. Because obtention of clinical material presents both logistics and quality problems for ongoing and intense studies of target validation, PREDECT aims to use material from genetically engineered mouse models, and some advanced xenografts, whose pathology and molecular profiles closely match cohorts of human tumors. PREDECT hopes to provide more appropriate in vitro platforms both for target validation and subsequent preclinical studies which will replace a current cascade of tests which are poorly predictive of clinical activity. The project is expected to shift paradigms in cell biology as well as in preclinical target validation where it should permit greater predictivity of drug efficacy in patient cohorts. | drug, oncology, drug development, basic research, in vitro, xenograft, breast, prostate, lung, pre-clinical, target validation, drug discovery |
is listed by: Consortia-pedia is related to: Roche is related to: Orion is related to: sigma-tau is related to: Janssen Research and Development is related to: AbbVie is related to: Institute of Cancer Research is related to: Ecole Polytechnique Federale de Lausanne; Lausanne; Switzerland is related to: VTT Technical Research Centre of Finland is related to: University of Helsinki; Helsinki; Finland is related to: University of Tartu; Tartu; Estonia is related to: Biomedicum Genomics is related to: Oncotest is related to: Institute of Experimental Biology and Technology; Oeiras; Portugal is related to: Cardiff University; Wales; United Kingdom has parent organization: University of Helsinki; Helsinki; Finland |
Innovative Medicines Initiative ; EFPIA |
nlx_158212 | SCR_003883 | SciCrunch Registry | Preclinical evaluation of drug efficacy in common solid tumours, Predect New models for preclinical evaluation of drug efficacy in common solid tumours | 2026-11-07 11:55:14 | 8 | |||||||
|
PharmaCog Resource Report Resource Website 10+ mentions |
PharmaCog (RRID:SCR_003878) | PharmaCog | consortium, data or information resource, organization portal, portal | Project aiming to tackle bottlenecks in Alzheimer''''s disease research and drug discovery by developing and validating new tools to test candidate drugs for the treatment of symptoms and disease in a faster and more sensitive way. They will provide the tools needed to define more precisely the potential of a drug candidate, reduce the development time of new medicines and thus accelerate the approvals of promising new medicines. By bringing together databases of previously conducted clinical trials and combining the results from blood tests, brain scans and behavioral tests, the scientists will develop a ''''signature'''' that gives more accurate information on the progression of the disease and the effect of candidate drugs than current methods do. The scientists will conduct parallel studies in laboratory models, healthy volunteers and patients in order to better predict good new drugs as early as possible. This will enable them, for instance, to find out how memory loss in Alzheimer''''s disease can be simulated in healthy volunteers, for example with sleep deprivation or drugs that temporarily affect the memory, in order to test the effect of candidate-medicines early in the drug development process. | drug, biomarker, drug discovery, model, tool development, drug development, medicine, clinical, pre-clinical, pharmacology, disease progression, cognitive impairment |
is listed by: Consortia-pedia is related to: Merck is related to: Janssen Research and Development is related to: Roche is related to: Eisai is related to: Aix-Marseille University; Provence-Alpes-Cote d'Azur; France is related to: Alzheimer Europe is related to: French National Center for Scientific Research is related to: Greek Association of Alzheimers Disease and Related Disorders is related to: August Pi i Sunyer Biomedical Research Institute; Barcelona; Spain is related to: National Institute of Health and Medical Research; Rennes; France is related to: Mario Negri Institute for Pharmacological Research; Milan; Italy is related to: University of Murcia; Murcia; Spain is related to: Catholic University of the Sacred Heart; Milan; Italy is related to: University of Foggia; Foggia; Italy is related to: University of Genoa; Genoa; Italy is related to: University of Perugia; Perugia; Italy is related to: University of Verona; Verona; Italy is related to: University of Leipzig; Saxony; Germany is related to: Lille 2 University of Health and Law; Lille; France is related to: University of Exeter; Exeter; United Kingdom is related to: Innovative Concepts in Drug Development is related to: AlzProtect is related to: Qualissima is related to: Exonhit Therapeutics is related to: University of Bristol; Bristol; United Kingdom is related to: European Medicines Agency has parent organization: Lille 2 University of Health and Law; Lille; France has parent organization: Alzheimer Europe has parent organization: Aix-Marseille University; Provence-Alpes-Cote d'Azur; France |
Innovative Medicines Initiative 115009; EFPIA |
nlx_158206 | SCR_003878 | SciCrunch Registry | Prediction of cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development, Pharma-Cog | 2026-11-07 11:55:12 | 13 | |||||||
|
Patients to Trials Consortium Resource Report Resource Website |
Patients to Trials Consortium (RRID:SCR_003877) | Patients2Trials Consortium | community building portal, consortium, data or information resource, organization portal, people resource, portal, service resource | A three-member pharmaceutical industry consortium that aims to provide a new platform to improve access to information about clinical trials for patients and providers. The platform aims to enhance the existing clinicaltrials.gov by providing more detailed and patient-friendly information about available trials and embedding a machine-readable target health profile to improve the ability of healthcare software to match individual health profiles with applicable clinical trials. Using clinicaltrials.gov as its foundation and Eli Lilly''''s Application Programming Interface (API), the consortium is focused on creating an open platform to make this data more amenable to patients and providers, as well as creating an opportunity to integrate a patient''''s electronic health record into the clinical trial matching service. This feature will allow patients to search for trials using their own Blue Button data. The following features are planned add-ons to clinicaltrials.gov: * Target Profile is a machine readable query, that can be executed against an electronic file (or record) with patient health data such as an Electronic Health Record (EHR), an Electronic Medical Record (EMR) or Personally Controlled Health Record (PCHR) * Augmented Content is public, IRB approved information about the study that has not been published on clinicaltrials.gov, and that is shared with / targeted for patients with a matching Target Profile. The following are the incremental goals of the consortium: * Advancement of the Lilly API platform to support read/write interaction and additional data objects and information. * The initial 3 sponsor organizations - Lilly, Pfizer and Novartis - will upload Target Profiles for a select set of clinical trials. A Target Profile is a machine interpretable description of the characteristics of patients who may qualify for that trial i.e. a query that can be executed against a patient''''s electronic health record or personal health record. Additionally, sponsors of clinical research studies will also be able to upload Augmented Content to the Lilly Platform to supplement information on clinicaltrials.gov with additional, patient-focused information about the study, e.g., a study brochure and practical information on how to contact investigational sites. * A matching service, developed by Corengi, will compare Target Profiles to a de-dentified personally controlled health record (PCHR), represented by patient''''s Blue Button Plus CCDA XML document. * Integration into a patient community platform from Avado for providing the patient PCHR and presenting the results of the match service. The patient will be able to explore the respective matching studies for additional information and next steps such as contacting a nearby investigator clinic or hospital. The first demo of the prototype was made available on June 2014, built on a database of anonymized patient health records from different clinical research studies sponsored by Lilly, Novartis, and Pfizer. Other website: http://portal.lillycoi.com/ | drug development, tool development, clinical trial, clinical, patient profile, clinical research study, health record, platform, database |
uses: ClinicalTrials.gov is listed by: Consortia-pedia is related to: Pfizer Animal Genetics is related to: Corengi |
Open unspecified license, Public | nlx_158205 | SCR_003877 | SciCrunch Registry | p2t consortium | 2026-11-07 11:55:13 | 0 | |||||||
|
Chevron Corporation Resource Report Resource Website 1+ mentions |
Chevron Corporation (RRID:SCR_003794) | Chevron, CVX | commercial organization | An American multinational energy corporation headquartered in San Ramon, California, and active in more than 180 countries, that is engaged in every aspect of the oil, gas, and geothermal energy industries, including exploration and production; refining, marketing and transport; chemicals manufacturing and sales; and power generation. Chevron is one of the world's largest oil companies; as of 2013, it ranked third in the Fortune Global 500-2014 list of the world's largest companies. (Adapted from Wikipedia) | oil, gas, geothermal energy, chemicals manufacturing, power generation | Crossref funder ID: 100004366, grid.450626.3, ISNI: 0000 0004 0599 8199, Wikidata: Q319642, nlx_158090 | https://ror.org/02jfa8730 | SCR_003794 | SciCrunch Registry | Chevron Corp., Chevron Corp | 2026-11-07 11:55:11 | 1 | ||||||||
|
Charles River Laboratories Resource Report Resource Website 10000+ mentions |
Charles River Laboratories (RRID:SCR_003792) | CRL | biomaterial supply resource, material resource, organism supplier | Commercial organism provider selling mice, rats and other model animals. American corporation specializing in a variety of pre-clinical and clinical laboratory services for the pharmaceutical, medical device and biotechnology industries. It also supplies assorted biomedical products and research and development outsourcing services for use in the pharmaceutical industry. (Wikipedia) | RIN, Resource Information Network, pre-clinical, clinical, pharmaceutical, medical device, biotechnology, drug, drug discovery, RRID Community Authority |
is listed by: Resource Information Network is related to: Oncotest works with: International Mouse Strain Resource |
SCR_013551, grid.452317.6, nif-0000-00462, nlx_158088, Wikidata: Q28974283 | https://ror.org/01tasya06 | SCR_003792 | SciCrunch Registry | Charles River Laboratories Inc., Charles River, Charles River Laboratories International Inc. | 2026-11-07 11:55:29 | 11510 | |||||||
|
BioReliance Resource Report Resource Website 50+ mentions |
BioReliance (RRID:SCR_003791) | BREL | commercial organization | Company that provides testing and manufacturing services to pharmaceutical and biopharmaceutical companies that span the product cycle from early pre-clinical development to licensed production. | testing, manufacturing, pharmaceutical, biopharmaceutical |
has parent organization: Sigma-Aldrich is parent organization of: BioReliance Biorepository |
nlx_158085 | SCR_003791 | SciCrunch Registry | BioReliance Corporation, BioReliance Corp. | 2026-11-07 11:55:01 | 62 | ||||||||
|
Minimal Standard Terminology of Digestive Endoscopy - French Resource Report Resource Website |
Minimal Standard Terminology of Digestive Endoscopy - French (RRID:SCR_003830) | MSTDE-FRE | controlled vocabulary, data or information resource, ontology | Metathesaurus Version of Minimal Standard Terminology Digestive Endoscopy, French Translation, 2001 | umls | is listed by: BioPortal | nlx_157484 | SCR_003830 | SciCrunch Registry | Minimal Standard Terminology of Digestive Endoscopy French | 2026-11-07 11:55:12 | 0 | ||||||||
|
Antilope Project Resource Report Resource Website 1+ mentions |
Antilope Project (RRID:SCR_003829) | Antilope | consortium, data or information resource, narrative resource, organization portal, portal, standard specification | Consortium focused on making electronic health data more interoperable, both within and outside of Europe, with the intention to create, validate, and disseminate standard methods to test and certify electronic health solutions and services. In particular it will: Drive the adoption of recognized sets of profiles and underlying standards for eHealth interoperability, and improve the impact of the EU and International eHealth standards development process; Define and validate testing guidelines and common approaches on Interoperability Labelling and Certification processes at European and at National / Regional level. Four work packages were created to provide guidelines, recommendations and frameworks based on a set of use cases, related profiles and standards, Interoperability Quality Management System, testing guidelines and Certification process. All the deliverables will be presented for validation and promotion by organizing workshops across Europe. | consortium, interoperability, electronic health data, data sharing, testing, certification, ehealth | is listed by: Consortia-pedia | European Union FP7 325077 | nlx_158143 | SCR_003829 | SciCrunch Registry | 2026-11-07 11:55:30 | 1 | ||||||||
|
Selleck Chemicals LLC Resource Report Resource Website 100+ mentions |
Selleck Chemicals LLC (RRID:SCR_003823) | commercial organization | An Antibody supplier | antibody, chemical supply, selleck chemicals | nlx_152457 | SCR_003823 | SciCrunch Registry | Selleck Chemicals | 2026-11-07 11:55:11 | 235 | ||||||||||
|
BioClinica Resource Report Resource Website 100+ mentions |
BioClinica (RRID:SCR_003789) | BioClinica | commercial organization | Pennsylvania-based company supporting pharmaceutical and medical device innovation with imaging core lab, EDC, IVR / IWR, CTMS, and supply chain forecasting and optimization. Its initial service was medical imaging for clinical trials. It is used to capture, collect, control quality, provide blinded reading services to the final delivery to the sponsor company and to the FDA or EMEA if required for medical images in a wide range of imaging modalities. (Wikipedia) | clinical trial, pharmaceutical, medical device, medical imaging, cardiac safety, clinical | Crossref funder ID: 100007742, ISNI: 0000 0004 0602 1531, Wikidata: Q4914605, grid.430790.9, nlx_158082 | https://ror.org/03t95yr58 | SCR_003789 | SciCrunch Registry | BioClinica Inc. | 2026-11-07 11:55:11 | 101 | ||||||||
|
Medical University of South Carolina; South Carolina; USA Resource Report Resource Website 1+ mentions |
Medical University of South Carolina; South Carolina; USA (RRID:SCR_003828) | MUSC | university | Public medical school in Charleston, South Carolina. Opened in 1824 as small private college aimed at training physicians. One of the oldest continually operating schools of medicine in the United States and the oldest in the Deep South. |
is affiliated with: NIH StrokeNet is related to: Clinical and Translational Science Awards Consortium is parent organization of: MUSC Health News is parent organization of: Hollings Cancer Center Tissue Biorepository and Research Pathology Services Shared Resource is parent organization of: SPARC Request is parent organization of: Medical University of South Carolina Department of Cell and Molecular Pharmacology and Experimental Therapeutics is parent organization of: Medical University of South Carolina Center on Aging is parent organization of: MUSC Health Podcast Library is parent organization of: Charleston Heart Study is parent organization of: Diffusional Kurtosis Estimator is parent organization of: ArrayQuest is parent organization of: MUSC DNA Microarray Database is parent organization of: NiiStat is parent organization of: MRIcroS is parent organization of: Medical University of South Carolina College of Dental Medicine Gnotobiotic Animal Core Facility is parent organization of: University of South Carolina Electron Microscopy Core Facility is parent organization of: Medical University of South Carolina Hollings Cancer Center Cell and Molecular Imaging Core Facility is parent organization of: Medical University of South Carolina MUSC Mouse Behavior Phenotyping Core Facility is parent organization of: Medical University of South Carolina AI High Performance Computing Core |
GRID grid.259828.c, , nlx_34109, Wikidata Q6806451, ISNI 0000 0001 2189 3475, Crossref Funder ID 100006942 | https://ror.org/012jban78 | SCR_003828 | SciCrunch Registry | Medical University of South Carolina | 2026-11-07 11:55:02 | 3 | ||||||||
|
AirPROM Resource Report Resource Website |
AirPROM (RRID:SCR_003827) | AirPROM | consortium, data or information resource, organization portal, portal | Consortium focused on developing computer and physical models of the airway system for patients with asthma and chronic obstructive pulmonary disease (COPD). Developing accurate models will better predict how asthma and COPD develop, since current methods can only assess the severity of disease. They aim to bridge the gaps in clinical management of airways-based disease by providing reliable models that predict disease progression and the response to treatment for each person with asthma or COPD. A data management platform provides a secure and sustainable infrastructure that semantically integrates the clinical, physiological, genetic, and experimental data produced with existing biomedical knowledge from allied consortia and public databases. This resource will be available for analysis and modeling, and will facilitate sharing, collaboration and publication within AirPROM and with the broader community. Currently the AirPROM knowledge portal is only accessible by AirPROM partners. | model, airway system, lung, consortium, clinical, imaging, respiratory system, tissue sample, airway model, genomic, gas diffusion mri, airway development, function, physiological, genetic, computational model, gene-environment interaction |
is listed by: Consortia-pedia has parent organization: European Lung Foundation |
European Union FP7 | nlx_158142 | SCR_003827 | SciCrunch Registry | Airway Disease Predicting Outcomes through Patient Specific Computational Modelling | 2026-11-07 11:55:11 | 0 | |||||||
|
Quretec Resource Report Resource Website 1+ mentions |
Quretec (RRID:SCR_003826) | Quretec | commercial organization | Commercial organization that builds software for collection, management, and analysis of complex data, most typical in biomedical domain. The solutions are generic and can be used for multitude of uses and application domains. | data capture, data management, analysis, biomedical | is related to: AgedBrainSYSBIO | Wikidata: Q30291134, grid.436973.c, nlx_158133 | https://ror.org/02ca38p84 | SCR_003826 | SciCrunch Registry | Quretec Ltd., Quretec Ltd | 2026-11-07 11:55:12 | 2 | |||||||
|
AgedBrainSYSBIO Resource Report Resource Website 1+ mentions |
AgedBrainSYSBIO (RRID:SCR_003825) | AgedBrainSYSBIO | consortium, data or information resource, organization portal, portal | Consortium focused on identifying the foundational pathways responsible for the aging of the brain, with a focus on Late Onset Alzheimer's disease. They aim to identify the interactions through which the aging phenotype develops in normal and in disease conditions; modeling novel pathways and their evolutionary properties to design experiments that identify druggable targets. As early steps of neurodegenerative disorders are expected to impact synapse function the project will focus in particular on pre- or postsynaptic protein networks. The concept is to identify subsets of pathways with two unique druggable hallmarks, the validation of interactions occurring locally in subregions of neurons and a human and/or primate accelerated evolutionary signature. The consortium will do this through six approaches: * identification of interacting protein networks from recent Late-Onset Alzheimer Disease-Genome Wide Association Studies (LOAD-GWAS) data, * experimental validation of interconnected networks working in subregion of a neuron (such as dendrites and dendritic spines), * inclusion of these experimentally validated networks in larger networks obtained from available databases to extend possible protein interactions, * identification of human and/or primate positive selection either in coding or in regulatory gene sequences, * manipulation of these human and/or primate accelerated evolutionary interacting proteins in human neurons derived from induced Pluripotent Stem Cells (iPSCs) * modeling predictions in drosophila and novel mouse transgenic models * validation of new druggable targets and markers as a proof-of-concept towards the prevention and cure of aging cognitive defects. The scientists will share results and know-how on Late-Onset Alzheimer Disease-Genome Wide Association Studies (LOAD-GWAS) gene discovery, comparative functional genomics in mouse and drosophila models, in mouse transgenic approaches, research on human induced pluripotent stem cells (hiPSC) and their differentiation in vitro and modeling pathways with emphasis on comparative and evolutionary aspects. The four European small to medium size enterprises (SMEs) involved will bring their complementary expertise and will ensure translation of project results to clinical application. | consortium, drug, drug development, brain, phenotype, presynaptic, protein network, postsynaptic, systems biology, synapse, neuron, protein interaction, network, induced pluripotent stem cell, pathway, genome wide association study, cognitive defect, gene, protein |
is listed by: Consortia-pedia is related to: Pasteur Institute of Lille; Lille; France is related to: Mouse Clinical Institute; Alsace; France is related to: Hybrigenics is related to: Inserm Transfert is related to: VIB; Flanders; Belgium is related to: Quretec is related to: Gene Bridges is related to: European Bioinformatics Institute is related to: Tel Aviv University; Ramat Aviv; Israel is related to: SIB Swiss Institute of Bioinformatics is related to: Babraham Institute has parent organization: National Institute of Health and Medical Research; Rennes; France has parent organization: Inserm Transfert |
European Union FP7 305299 | nlx_158132 | SCR_003825 | SciCrunch Registry | 2026-11-07 11:55:30 | 3 | ||||||||
|
Onyx Pharmaceuticals Resource Report Resource Website 1+ mentions |
Onyx Pharmaceuticals (RRID:SCR_003782) | Onyx, ONXX | commercial organization | November 2020, Onyx merged with Legacy Acquisition Corp. to form PARTS iD, Inc. Our data intelligence, integrated platforms, product cataloging, digital marketing expertise, and virtual warehousing have ensured our continued leadership in the competitive marketplace. | drug, pharmaceutical, biotechnology | nlx_158070 | https://www.biospace.com/employer/540942/onyx-pharmaceuticals-inc-/ | SCR_003782 | SciCrunch Registry | Onyx Pharmaceuticals Inc. | 2026-11-07 11:55:11 | 5 | ||||||||
|
Sciencewise Resource Report Resource Website |
Sciencewise (RRID:SCR_003780) | Sciencewise | knowledge environment | Sciencewise-ERC is the UK's national center for public dialogue in policy making involving science and technology issues. It provides co-funding and specialist advice and support to Government departments and agencies to develop and commission public dialogue activities in emerging areas of science and technology. It consists of a comprehensive online resource of information, advice and guidance together with a wide range of support services aimed at policy makers and all the different stakeholders involved in science and technology policy making, including the public. Sciencewise-ERC works with central Government and its agencies, and executive, advisory and non-departmental public bodies. Some of the Government departments include the Department for Environment, Food and Rural Affairs (Defra), the Department of Energy and Climate Change (DECC) and most recently HM Treasury. | public dialogue | Department for Business Innovation and Skills BIS UK Gov | nlx_143528 | SCR_003780 | SciCrunch Registry | Sciencewise - ERC, Sciencewise Expert Resource Center, Sciencewise Expert Resource Centre for Public Dialogue In Science and Innovation, Sciencewise Expert Resource Centre, Sciencewise-ERC | 2026-11-07 11:55:28 | 0 | ||||||||
|
European Federation of Pharmaceutical Industries and Associations Resource Report Resource Website 10+ mentions |
European Federation of Pharmaceutical Industries and Associations (RRID:SCR_003820) | EFPIA | institution | Federation representing the pharmaceutical industry operating in Europe. Through its direct membership of 33 national associations and 40 leading pharmaceutical companies, it is the voice on the EU scene of 1,900 companies committed to researching, developing and manufacturing new medical treatments. In addition, it is active in partnering in EU Research programmes, such as the IMI (Innovative Medicines Initiative), Europe's largest public-private partnerships. They also work on corporate social responsibility initiatives with others healthcare stakeholders, such as patient groups and healthcare professionals. EFPIA has specialized committees and task forces focused on key areas of activity. EFPIA also includes two specialized groups focusing on vaccines and biotechnology, respectively: * Vaccines Europe (formerly European Vaccine Manufacturers, EVM) produces approximately 80% of vaccines used worldwide * European Biopharmaceutical Enterprises (EBE) harness biotechnology to develop approximately one-fifth of new medicines | pharmaceutical, medicine, vaccine, biotechnology, manufacturing, corporate |
is affiliated with: Merck is affiliated with: Roche is related to: Innovative Medicines Initiative is parent organization of: Innovative Medicines Initiative |
grid.484123.8, nlx_158124, ISNI: 0000 0000 9246 8110, Wikidata: Q1376562 | https://ror.org/00g1x4v36 | SCR_003820 | SciCrunch Registry | 2026-11-07 11:55:02 | 20 | ||||||||
|
Avid Radiopharmaceuticals Resource Report Resource Website |
Avid Radiopharmaceuticals (RRID:SCR_003786) | commercial organization | Subsidiary of Eli Lilly and Company who develops new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies. The company has developed a radioactive tracer called florbetapir (18F). Florbetapir can be used to detect beta amyloid plaques in patients with memory problems using positron emission tomography (PET) scans, making the company the first to bring to market an FDA-approved method that can directly detect this hallmark pathology of Alzheimer's disease. | molecular imaging agent, beta amyloid plaque, pet | Alzheimer's disease | nlx_158076 | SCR_003786 | SciCrunch Registry | Avid Radiopharmaceuticals Inc. | 2026-11-07 11:55:11 | 0 | |||||||||
|
BioSHaRE Resource Report Resource Website 10+ mentions |
BioSHaRE (RRID:SCR_003811) | BIOSHARE-EU | consortium, data or information resource, narrative resource, organization portal, portal, standard specification | A consortium of leading biobanks and international researchers from all domains of biobanking science to ensure the development of harmonized measures and standardized computing infrastructures enabling the effective pooling of data and key measures of life-style, social circumstances and environment, as well as critical sub-components of the phenotypes associated with common complex diseases. The overall aim is to build upon tools and methods available to achieve solutions for researchers to use pooled data from different cohort and biobank studies. This, in order to obtain the very large sample sizes needed to investigate current questions in multifactorial diseases, notably on gene-environment interactions. This aim will be achieved through the development of harmonization and standardization tools, implementation of these tools and demonstration of their applicability. BioSHaRE researchers are collaborating with P3G, the Global Alliance for Genomics and Health, IRDiRC (International Rare Diseases Research Consortium), H3Africa and other organizations on the development of an International Code of Conduct for Genomic and Health-Related Data Sharing. A draft version is available for external review. Generic documents have been prepared covering areas of biobanking that are of major importance. SOPs have been finalized for blood withdrawal (SOPWP5001blood withdrawal), manual blood processing (SOPWP5002blood processing), shipping of biosamples (SOPWP5003shipping) and withdrawal, processing and storage of urine samples (SOPWP5004urine). | gene-environment interaction, life-style, social circumstance, environment, phenotype, disease, biobank, socio-economic factor, data sharing, gene, clinical |
is listed by: Consortia-pedia has parent organization: University of Groningen; Groningen; Netherlands is parent organization of: BioResource Impact Factor |
European Union FP7 | nlx_158110 | SCR_003811 | SciCrunch Registry | Biobank Standardisation and Harmonisation for Research Excellence, Biobank Standardisation and Harmonisation for Research Excellence in the European Union | 2026-11-07 11:55:11 | 22 | |||||||
|
Olink Bioscience Resource Report Resource Website 100+ mentions |
Olink Bioscience (RRID:SCR_003899) | Olink | commercial organization | Commercial organization that produces products for biomarker research and development. Their goal is to help customers and collaborators to improve clinical decisions through the use of molecular biomarkers. Their tools bring new insights into disease processes, improve disease detection, and contribute to a better understanding of biology. | biomarker, disease | is related to: READNA | nlx_158232 | SCR_003899 | SciCrunch Registry | 2026-11-07 11:55:04 | 342 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the ASWG Resources search. From here you can search through a compilation of resources used by ASWG and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that ASWG has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on ASWG then you can log in from here to get additional features in ASWG such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into ASWG you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
Welcome to the ASWG Community.
Our Information
